MED8 anticorps (Middle Region)
Aperçu rapide pour MED8 anticorps (Middle Region) (ABIN953379)
Antigène
Voir toutes MED8 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 102-130, Middle Region
-
Specificité
- This antibody recognizes Human MED8 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 102-130 amino acids from the Central region of human MED8
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- MED8 (Mediator Complex Subunit 8 (MED8))
-
Autre désignation
- MED8
-
Sujet
- This gene encodes a protein that is one of more than 20 subunits of the mediator complex, first identified in S. cerevisiae, that is required for activation of transcription. The product of this gene also interacts with elongins B and C, and CUL2 and RBX1, to reconstitute a ubiquitin ligase. Two alternative transcripts encoding different isoforms have been described.Synonyms: Activator-recruited cofactor 32 kDa component, Mediator complex 8, Mediator of RNA polymerase II transcription subunit 8
-
Poids moléculaire
- 29080 Da
-
ID gène
- 112950
-
NCBI Accession
- NP_443109
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-